Could a simple drug shorten labor? new trial tests papaverine
NCT ID NCT07237880
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a single dose of papaverine, a muscle relaxant, can safely shorten the second stage of labor in pregnant women who had a balloon catheter to start labor. Researchers will compare labor times and outcomes between women who get papaverine and those who get a placebo. The trial aims to find a simple way to reduce labor duration and improve the birth experience.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- papaverine
- What this could lead to
- If it works, this could offer a simple, safe way to shorten labor for women after cervical ripening, potentially reducing discomfort and complications.
- What could go wrong
- This is an early-stage trial with only 184 participants. The drug may not shorten labor significantly, and there is a small risk of side effects like allergic reactions or effects on the baby.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LABOR, INDUCED are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hillel Yaffe Medical Center
RECRUITINGHadera, Israel
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Simple finger sweep vs balloon: which gets labor started better?
- Which Labor-Inducing drug works best for First-Time moms?
- Which labor induction method is safer for moms and babies?
- Does knowing more about labor induction make childbirth better?
- Can a numbing cream make labor induction less painful?
- Could a simple pill let women start labor at home?